StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX)
StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. DURECT Stock Performance Shares of NASDAQ:DRRX opened at $0.80 on Wednesday. The firm has a 50 day moving average of $0.80 and […]
StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. DURECT Stock Performance Shares of NASDAQ:DRRX opened at $0.80 on Wednesday. The firm has a 50 day moving average of $0.80 and […]
